Ensuring histocompatibility in the tissue engineering of bones is a complex issue. The aim of this study was to observe the feasibility of chitosanβtricalcium phosphate composite in repairing limb bone defects, and to evaluate the therapeutic effects on osteogenesis. Beagle mesenchymal
stem cells (MSCs) were divided into an experimental group that was cultured with an injectable form of chitosanβtricalcium phosphate composite and a control group. The effect of the composite on bone tissue growth was evaluated by MTT assay. In addition, 12monthold beagles were subjected
to 15mm femur defects and subsequently implanted with scaffolds to observe the effects on osteogenesis and vascularization. The dogs were subdivided into two groups of five animals: Group A, which was implanted with scaffoldMSC compounds, and Group B, which was implanted with scaffolds
alone. The dogs were observed on the 2nd, 4th, 8th and 12th weeks postimplantation. Scanning electron microscopy analysis revealed that the composite was compatible with MSCs, with similar outcomes in the control and experimental groups. MTT analysis additionally showed that the MSCs in the
experimental group grew in a similar manner to those in the control group. The composite did not significantly affect the MSC growth or proliferation. In combination with MSCs, the scaffold materials were effective in the promotion of osteogenesis and vascularization. In conclusion, the chitosanβtricalcium
phosphate composite was compatible with the MSCs and did not affect cellular growth or proliferation, therefore proving to be an effective injectable composite for tissue engineered bone. Simultaneous implantation of stem cells with a carrier composite proved to function effectively in the
repair of bone defects.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Saint Petersburg State I.P. Pavlov Medical University, St. Petersburg 197101, Russia
Department of Orthopedics, Hukou County Hospital of Traditional Chinese Medicine, Hukou, Jiangxi 332500, P.R. China
Department of Orthopedics, The People's Hospital of Bishan County, Bishan, Chongqing 402760, P.R. China
Department of Orthopedics, Zibo Zhangdian Hospital of Traditional Chinese Medicine, Zibo, Shandong 255035, P.R. China
Department of Orthopedics, The 301 Military Hospital, Beijing 100853, P.R. China
Publication date: August 1, 2015
More about this publication?
Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites